Usher’s syndrome type II (USH2) is characterized by moderate to profound congenital hearing loss, later onset of retinitis pigmentosa, and normal vestibular function. Recently, a study investigating the vestibular function of USH2 patients demonstrated a pathologic response to vestibular tests. In this cross-sectional study we performed vestibular tests of a group patients with genetic diagnosis of USH2 syndrome to demonstrate if vestibular damage is present in USH2 patients.
Study Design
Cross-sectional study.
Setting
Tertiary referral center.
Subjects and Methods
Mutated genes of 7 patients with a clinical diagnosis of USH2 were evaluated. Vestibular function was investigated by audiometry, Fitzgerald-Hallpike caloric vestibular testing, cervical vestibular evoked myogenic potentials (C-VEMPs), ocular vestibular evoked myogenic potentials (O-VEMPs), and video head impulse test (v-HIT).
Results
Genetic tests confirmed the USH2 diagnosis in 5 of 7 patients examined, with 1 patient reporting a unique mutation on genetic tests. Four (80%) of the 5 patients with a genetic diagnosis of USH2 showed pathological O-VEMPs. Two patients (40%) reported bilateral absent or abnormal values of C-VEMPs. The superior semicircular canal presented a significant deficit in 2 (40%) patients. The same 2 cases showed a pathologic response of the v-HIT of the horizontal semicircular canal. Finally, the posterior semicircular canal presented a significant deficit in 4 (40.0%) patients.
Conclusion
A vestibular evaluation with vestibular evoked myogenic potentials and v-HIT seems to identify latent damage to the vestibular receptors of USH2 patients.
LentzJKeatsB.Usher syndrome type II. In: PagonRAAdamMPArdingerHHWallaceSEAmemiyaABeanLJHet al, eds. GeneReviews®. Seattle: University of Washington; 1993-2017.
8.
Blanco-KellyFJaijoTAllerEAvila-FernandezAet al. Clinical aspects of Usher syndrome and the USH2A gene in a cohort of 433 patients. JAMA Ophthalmol. 2015;133:157-164.
9.
YanDLiuXZ.Genetics and pathological mechanisms of Usher syndrome. J Hum Genet. 2010;55:327-335.
10.
SadeghiMCohnESKellyWJKimberlingWJTranebjoergLMöllerC.Audiological findings in Usher syndrome types IIa and II (non-IIa). Int J Audiol. 2004;43:136-143.
11.
WagenaarMvan AaremAHuygenPPieke-DahlSKimberlingWCremersC.Hearing impairment related to age in Usher syndrome types 1B and 2A. Arch Otolaryngol Head Neck Surg. 1999;125:441.
12.
YasuyukiHSatoshiIMitsuyoshiNet al. Clinical evaluation of 6 patients in Usher syndrome type II and III. Audiol Jpn. 2005;48:214-219.
13.
PiekeDahl SKimberlingWJGorinMBWestonMDet al. Genetic heterogeneity of Usher syndrome type II. J Med Genet. 1993;30:843-848.
14.
HmaniMGhorbelABoulila-ElgaiedAet al. A novel locus for Usher syndrome type II, USH2B, maps to chromosome 3 at p23-24.2. Eur J Hum Genet. 1999;7:363-367.
15.
LiuXZHopeCLiangCYet al. A mutation (2314delG) in the Usher syndrome type IIA gene: high prevalence and phenotypic variation. Am J Hum Genet. 1999;64:1221-1225.
16.
MagliuloGIannellaGGagliardiSet al. Usher’s syndrome: evaluation of the vestibular system with cervical and ocular vestibular evoked myogenic potentials and the video head impulse test. Otol Neurotol. 2015;36:1421-1427.
17.
PenningsRJTopsakalVAstutoLet al. Variable clinical features in patients with CDH23 mutations (USH1D DFNB12). Otol Neurotol. 2004;25:699-706.
18.
BischoffAMPenningsRJHuygenPLet al. Cochleovestibular and ocular features in a Dutch DFNA11 family. Otol Neurotol. 2006;27:323-331.
19.
HartelBPPenningsRJvan WijkE.Comment on “Usher’s syndrome: evaluation of the vestibular system with cervical and ocular vestibular evoked myogenic potentials and the video head impulse test.”Otol Neurotol. 2016;37:608.
20.
MagliuloGIannellaG.Response to letter to the editor: comment on “Usher’s syndrome: evaluation of the vestibular system with cervical and ocular vestibular evoked myogenic potentials and the video head impulse test.”Otol Neurotol. 2016;37:609.
21.
MillánJMAllerEJaijoTet al. An update on the genetics of usher syndrome. J Ophthalmol. 2011;2011:417217.
22.
BesnardTGarcía-GarcíaGBauxDet al. Experience of targeted Usher exome sequencing as a clinical test. Mol Genet Genomic Med. 2014;2:30-43.
23.
ZongLChenKWuXLiuMJiangH.Compound heterozygous MYO7A mutations segregating Usher syndrome type 2 in a Han family. Int J Pediatr Otorhinolaryngol. 2016;90:150-155.
24.
VozziDAaspõlluAAthanasakisEet al. Molecular epidemiology of Usher syndrome in Italy. Mol Vis. 2011;17:1662-1668.
25.
MagliuloGGagliardiSCiniglio AppianiMIannellaGGagliardiM.Selective vestibular neurolabyrinthitis of the lateral and superior semicircular canal ampulla and ampullary nerves. Ann Otol Rhinol Laryngol. 2012;121:640-644.
26.
MagliuloGGagliardiSCiniglioAppianiMIannellaGReM.Vestibular neurolabyrinthitis: a follow-up study with cervical and ocular vestibular evoked myogenic potentials and the video head impulse test. Ann Otol Rhinol Laryngol. 2014;123:162-173.
27.
IwasakiSFujimotoCKinoshitaMKamogashiraTEgamiNYamasobaT.Clinical characteristics of patients with abnormal ocular/cervical vestibular evoked myogenic potentials in the presence of normal caloric responses. Ann Otol Rhinol Laryngol. 2015;124:458-465.
28.
MagliuloGIannellaGGagliardiSReM.A 1-year follow-up study with C-VEMPs, O-VEMPs and video head impulse testing in vestibular neuritis. Eur Arch Otorhinolaryngol. 2015;272:3277-3281.
29.
MagliuloGGagliardiMCiniglio AppianiGD’AmicoR.Preservation of the saccular nerve and of the vestibular evoked myogenic potential during vestibular schwannoma surgery. Otol Neurotol. 2003;24:308-311.
30.
MagliuloGCuiuliGGagliardiMCiniglio-AppianiGD’AmicoR.Vestibular evoked myogenic potentials and glycerol testing. Laryngoscope. 2004;114:338-343.
31.
BesnardTVachéCBauxDet al. Non-USH2A mutations in USH2 patients. Hum Mutat. 2012;33:504-510.
32.
EbermannIWiesenMHZrennerEet al. GPR98 mutations cause Usher syndrome type 2 in males. J Med Genet. 2009;46:277-280.
33.
KahriziKBazazzadeganNJamaliLet al. A novel mutation of the USH2C (GPR98) gene in an Iranian family with Usher syndrome type II. J Genet. 2014;93:837-841.
34.
MagliuloGIannellaGGagliardiSet al. Retinitis pigmentosa: evaluation of the vestibular system with cervical and ocular vestibular evoked myogenic potentials and the video head impulse test. Otol Neurotol. 2015;36:273-276.
35.
CohenMBitner-GlindziczMLuxonL.The changing face of Usher syndrome: clinical implications. Int J Audiol. 2007;46:82-93.
36.
McGeeTLSeyedahmadiBJSweeneyMODryjaTPBersonEL.Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa. J Med Genet. 2010;47:499-506.
37.
CiumanRR.Auditory and vestibular hair cell stereocilia: relationship between functionality and inner ear disease. J Laryngol Otol. 2011;125:991-1003.
38.
SadeghiAMCohnESKimberlingWJHalvarssonGMöllerC.Expressivity of hearing loss in cases with Usher syndrome type IIA. Int J Audiol. 2013;52:832-837.
39.
SoruschNWunderlichKBaussKNagel-WolfrumKWolfrumU.Usher syndrome protein network functions in the retina and their relation to other retinal ciliopathies. Adv Exp Med Biol. 2014;801:527-533.
40.
PiattiGDe SantiMMBrogiMCastorinaPAmbrosettiU.Emerging ciliopathies: are respiratory cilia compromised in Usher syndrome?Am J Otolaryngol. 2014;35:340-346.
41.
Di PalmaFHolmeRHBrydaECet al. Mutations in Cdh23, encoding a new type of cadherin, cause stereocilia disorganization in waltzer, the mouse model for Usher syndrome type 1D. Nat Genet. 2001;27:103-107.
42.
PanLZhangM.Structures of Usher syndrome 1 proteins and their complexes. Physiology (Bethesda). 2012;27:25-42.
43.
CosgroveDZallocchiM.Usher protein functions in hair cells and photoreceptors. Int J Biochem Cell Biol. 2014;46:80-89.
